Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
ASPEN AEROGELS INC reported the fourth quarter and full year 2023, which ended December 31, 2023 results: revenue $238.7 million, net income Net loss for the year was $45.8 million, EPS Net loss per share for the year was $0.66.
- Period
- the fourth quarter and full year 2023, which ended December 31, 2023
- Revenue
- $238.7 million
- Net income
- Net loss for the year was $45.8 million
- EPS
- Net loss per share for the year was $0.66
- Result
- reported results
Exact text from the filing
(EX-99.1) --- EX-99.1 Exhibit 99.1 Aspen Aerogels, Inc. Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Business Highlights For Immediate Release $84.2 million quarterly revenue enabled gross margins of 35% and adjusted EBITDA of $9.1 million NORTHBOROUGH, Mass., February 12, 2024 — Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
ASPEN AEROGELS INC reported the fourth quarter and full year 2023, which ended December 31, 2023 results: revenue $238.7 million, net income Net loss for the year was $45.8 million, EPS Net loss per share for the year was $0.66.
- Period
- the fourth quarter and full year 2023, which ended December 31, 2023
- Revenue
- $238.7 million
- Net income
- Net loss for the year was $45.8 million
- EPS
- Net loss per share for the year was $0.66
- Result
- reported results
Exact text from the filing
Total revenue for the full year 2023 was $238.7 million, compared to $180.4 million in 2022. Net loss for the year was $45.8 million, compared to a net loss of $82.7 million in 2022. Net loss per share for the year was $0.66, compared to $2.10 in 2022.
View on SEC.gov